These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7906553)

  • 21. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.
    Mickisch GH; Licht T; Merlino GT; Gottesman MM; Pastan I
    Cancer Res; 1991 Oct; 51(19):5417-24. PubMed ID: 1680550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in therapeutic indexes of combination metronomic chemotherapy and an anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts.
    Klement G; Huang P; Mayer B; Green SK; Man S; Bohlen P; Hicklin D; Kerbel RS
    Clin Cancer Res; 2002 Jan; 8(1):221-32. PubMed ID: 11801563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quantitative cytological study of the activity of a new resistance modulator, S 9788, on human leukemic cells using multiparametric image analysis].
    Oum'Hamed Z; Berlion M; Millot-Broglio C; Dufer J; Joly P; Bizzari JP; Desplaces A
    Bull Cancer; 1994 Mar; 81(3):203-11. PubMed ID: 7894128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788.
    Efferth T; Dunn TA; Berlion M; Langenbahn H; Pommerenke EW; Volm M
    Anticancer Res; 1993; 13(4):905-8. PubMed ID: 8102519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the pharmacological profile of an olivacine derivative and a potential prodrug.
    Kraus-Berthier L; Guilbaud N; Léonce S; Parker T; Genissel P; Guillonneau C; Goldstein S; Atassi G; Pierré A
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):95-103. PubMed ID: 12172972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors.
    Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM
    Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental study on combination chemotherapy of UFT and calcium antagonist in gastric cancer].
    Nakano GI; Katoh H; Ikeda H; Sakamoto K; Nagamachi Y
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):793-8. PubMed ID: 2496667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Circumvention of the intrinsic multidrug-resistance in renal cell carcinoma].
    Kakehi Y; Segawa T; Hashimura T; Yoshida O
    Hinyokika Kiyo; 1992 Nov; 38(11):1319-24. PubMed ID: 1485588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.
    Cucco C; Calabretta B
    Cancer Res; 1996 Oct; 56(19):4332-7. PubMed ID: 8813118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo reversibility of multidrug resistance by the MDR-modulator dexniguldipine (niguldipine derivative B859-35) and by verapamil.
    Dietel M; Boss H; Reymann A; Pest S; Seidel A
    J Exp Ther Oncol; 1996 Jan; 1(1):23-9. PubMed ID: 9414385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics by calcium channel blockers and calmodulin inhibitors].
    Tsuruo T
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):750-9. PubMed ID: 6585181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
    Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective modulation of P-glycoprotein-mediated drug resistance.
    Bebawy M; Morris MB; Roufogalis BD
    Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies.
    Galimberti S; Bianchi F; Bernardini N; Mattii L; Dolfi A; Lupetti M; Petrini M
    Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):543-51. PubMed ID: 8104068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a safe and effective adriamycin plus interleukin 2 therapy against both adriamycin-sensitive and -resistant lymphomas.
    Ho RL; Maccubbin D; Zaleskis G; Krawczyk C; Wing K; Mihich E; Ehrke MJ
    Oncol Res; 1993; 5(9):373-81. PubMed ID: 8038458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC; Guan Y; Soenen DR; Danishefsky SJ; Boger DL
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):379-90. PubMed ID: 15875185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y; Harada K; Ferdous T; Yoshida H
    Anticancer Res; 2007; 27(4B):2365-75. PubMed ID: 17695527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells.
    Fridborg H; Nygren P; Dhar S; Csoka K; Kristensen J; Larsson R
    J Exp Ther Oncol; 1996 Sep; 1(5):286-95. PubMed ID: 9414416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
    Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
    Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.